Home › Underage Drinking › NCT06486688
Centralized Virtual SBIRT for Pediatric Primary Care
Virtual SBIRT for Pediatric Primary Care: Increasing Access to Screening, Brief Intervention and Referral to Treatment for Alcohol and Other Drug Use Via Telehealth
Who can join
Ages 12 to 17 · All sexes
Full eligibility criteria
Inclusion Criteria: • The sample will include all adolescents aged 12 through 17 years seen for a Well Visit, who are at risk of AOD use disorder defined as endorsing monthly or more frequent AOD use OR any AOD use and past-two-week depressive symptoms or suicidality. Exclusion Criteria: • N/A - all adolescents with a Well Visit are eligible
About the study
Adolescent alcohol and other drug (AOD) use is a significant public health problem which contributes to high levels of mortality, morbidity and healthcare costs in young people, and identification and early intervention for these problems is critical to improving outcomes. Screening, Brief Intervention and Referral to Treatment (SBIRT) in pediatric primary care is an evidence-based strategy for addressing these problems, but has not been widely and systematically implemented, for a variety of reasons, including lack of training and staffing resources to support its implementation. This pragmatic, Type 1 Hybrid Comparative Effectiveness Implementation study will examine whether a centralized, virtually-delivered modality of SBIRT, rapidly accessible by multiple pediatric primary care clinics, can be cost-effectively implemented to improve early identification and treatment for AOD use and comorbid mental health problems among adolescents identified as being at high or severe risk of AOD use disorder during adolescent Well Visits.
What is being tested
- Centralized Virtual SBIRT (behavioral)
Sponsor: Kaiser Permanente · Participants: 22,320 · Started: Feb 13, 2024
Contact the study team
- Stacy A Sterling, DrPH, MSW · Phone: 5105028619
- Melanie Jackson-Morris · Phone: 9162040137
Official record on ClinicalTrials.gov — NCT06486688
Locations in the U.S.
| California | Kaiser Permanente Division of Research, Pleasanton |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.